This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Milberg LLP Announces Class Action Lawsuit Against China Sky One Medical, Inc.; Launches Case Website

Milberg LLP announces that a class action lawsuit was filed on behalf of all purchasers of China Sky One Medical, Inc. (Pink Sheets: CSKI) common stock between April 16, 2009 and February 14, 2012 (“Class Period”), in the United States District Court for the Southern District of New York.

Milberg LLP has created a website ( chinaskyonemedicallawsuit.com) that seeks to answer questions investors typically have about shareholder class actions.

The complaint alleges that China Sky One did not disclose to shareholders that during the Class Period the company improperly inflated earnings and gross margins and lacked adequate internal and financial controls.

On February 15, 2012, China Sky One disclosed the resignation of 26 middle-management level employees. On the same day, NASDAQ said it had halted trading in China Sky One’s shares until it received adequate “additional information requested” from the company. In reaction to the news, shares of China Sky One fell 28%, to close at $1.10 per share on February 15, 2012.

If you purchased China Sky One shares during the Class Period you may, no later than April 24, 2012, request that the Court appoint you lead plaintiff of the proposed class. A lead plaintiff is a class member that represents other class members in directing the litigation. Your share in any recovery will not be affected by serving as a lead plaintiff, however, lead plaintiffs make important decisions that could affect the overall recovery for class members. You do not need to be a lead plaintiff to recover. You may retain Milberg LLP, or other attorneys, for this action, but do not need to retain counsel to recover. If this action is certified as a class action, class members will be automatically represented by Court-appointed counsel. The complaint in this action was not filed by Milberg.

Milberg LLP has represented individual and institutional investors for over four decades and serves as lead counsel in Courts throughout the United States. Visit the Milberg website ( www.milberg.com) for more information about the firm. If you wish to discuss this matter with us, please contact the following attorneys:

Andrei Rado, Esq.

Milberg LLP

One Pennsylvania Plaza, 49th Fl.

New York, NY 10119-0165

Phone number: (800) 320-5081

Email: arado@milberg.com

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs